Wednesday June 5, 2019
04 Jun 2019 – Result of AGM
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Result of Annual General Meeting Brighton, United Kingdom – 4 June 2019 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company […]
Wednesday June 5, 2019
20 May 2019 – Destiny Pharma are part of the UK government Global Expert Mission d...
Destiny Pharma is part of the UKRI, InnovateUK and Knowledge Transfer Network’s Global Expert Mission delegation to Germany on Anti-Microbial Resistance, 20 – 24 May 2019. To find out more […]
Wednesday June 5, 2019
09 May 2019 – Pharmafocus publish article “The global rise in antibiotic res...
“Dr Bill Love, Founder and Chief Scientific Officer of Destiny Pharma, discusses the rise of antimicrobial resistance (AMR), the antibiotic stewardship required to offset this global threat, and the additional […]
Wednesday June 5, 2019
09 May 2019 – Destiny Pharma appoints NOMAD and Joint Broker
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Appointment of NOMAD and Joint Broker Brighton, United Kingdom – 9 May 2019 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology […]
Wednesday June 5, 2019